Published :
Tables : 52
Figures : 47
Category : Healthcare
No. of Pages : 233
Report Code : HC-U4602
Latin America Next Generation Sequencing Market is poised to value over CAGR of over 14.1% during the forecast period 2022 to 2028 FutureWise Market Research has instantiated a report that provides an intricate analysis of Latin America Next Generation Sequencing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Latin America Next Generation Sequencing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Latin America Next Generation Sequencing Market: • Illumina, Inc. • Thermo Fisher Scientific Inc. • Pacific Biosciences of California, Inc. • Qiagen N.V. • Oxford Nanopore Technologies Ltd • Bio-Rad Laboratories, Inc. • Beckman Coulter, Inc. • PerkinElmer, Inc. • F. Hoffmann-La Roche AG • 10x Genomics, Inc. . • Macrogen Inc. • Partek Inc. • Agilent Technologies Inc. • Genomatix Software GmbH • GATC Biotech Ag (Note: The list of the major players will be updated with the latest market scenario and trends) Latin America Next Generation Sequencing Market Segmentation: By Type • Consumables o Sample Preparation Consumables o DNA Fragmentation & Amplification o Library Preparation & Target Enrichment o Quality Control o Other Consumables • NGS Platforms/Instruments o Illumina NGS Platforms/Instruments o Thermo Fisher Scientific NGS Platforms/Instruments o Pacific Biosciences NGS Platforms/Instruments o Oxford Nanopore NGS Platforms/Instruments o Others • Software • Services By Sequencing Type • Whole Genome Sequencing • Whole Exome Sequencing • Targeted Sequencing • Others By Technology • Sequencing by Synthesis • Ion Semiconductor Sequencing • Sequencing by Ligation • Single-Molecule Real-Time Sequencing • Nanopore Sequencing • Others By Application • Clinical Application o Oncology o Reproductive Health Diagnostics o Non-Invasive Pre-natal Testing o Carrier Screening o In-Vitro fertilization o Newborn Screening o Cardiovascular o Others • Research Application o Drug Discovery o Agriculture & Animal Research o Others By End user • Clinical Diagnostic Laboratories • Pharmaceutical & Biotechnology Companies • Academic & Research Institutes • Others By Region • Brazil • Venezuela • Argentina • Rest of Latin America Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Latin America Next Generation Sequencing Market By Type, By Sequencing Type, By Technology, By Application, By End user and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— Brazil, Venezuela, Argentina, Rest of Latin America • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
FutureWise Market Research has instantiated a report that provides an intricate analysis of Latin America Next Generation Sequencing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Latin America Next Generation Sequencing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Latin America Next Generation Sequencing Market: • Illumina, Inc. • Thermo Fisher Scientific Inc. • Pacific Biosciences of California, Inc. • Qiagen N.V. • Oxford Nanopore Technologies Ltd • Bio-Rad Laboratories, Inc. • Beckman Coulter, Inc. • PerkinElmer, Inc. • F. Hoffmann-La Roche AG • 10x Genomics, Inc. . • Macrogen Inc. • Partek Inc. • Agilent Technologies Inc. • Genomatix Software GmbH • GATC Biotech Ag (Note: The list of the major players will be updated with the latest market scenario and trends) Latin America Next Generation Sequencing Market Segmentation: By Type • Consumables o Sample Preparation Consumables o DNA Fragmentation & Amplification o Library Preparation & Target Enrichment o Quality Control o Other Consumables • NGS Platforms/Instruments o Illumina NGS Platforms/Instruments o Thermo Fisher Scientific NGS Platforms/Instruments o Pacific Biosciences NGS Platforms/Instruments o Oxford Nanopore NGS Platforms/Instruments o Others • Software • Services By Sequencing Type • Whole Genome Sequencing • Whole Exome Sequencing • Targeted Sequencing • Others By Technology • Sequencing by Synthesis • Ion Semiconductor Sequencing • Sequencing by Ligation • Single-Molecule Real-Time Sequencing • Nanopore Sequencing • Others By Application • Clinical Application o Oncology o Reproductive Health Diagnostics o Non-Invasive Pre-natal Testing o Carrier Screening o In-Vitro fertilization o Newborn Screening o Cardiovascular o Others • Research Application o Drug Discovery o Agriculture & Animal Research o Others By End user • Clinical Diagnostic Laboratories • Pharmaceutical & Biotechnology Companies • Academic & Research Institutes • Others By Region • Brazil • Venezuela • Argentina • Rest of Latin America Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Latin America Next Generation Sequencing Market By Type, By Sequencing Type, By Technology, By Application, By End user and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— Brazil, Venezuela, Argentina, Rest of Latin America • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Latin America Next Generation Sequencing Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Latin America Next Generation Sequencing Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Latin America Next Generation Sequencing Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Latin America Next Generation Sequencing Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Consumables 7.1.1. Sample Preparation Consumables 7.1.1.1. DNA Fragmentation & Amplification 7.1.1.2. Library Preparation & Target Enrichment 7.1.1.3. Quality Control 7.1.2. Other Consumables 7.2. NGS Platforms/Instruments 7.2.1. Illumina NGS Platforms/Instruments 7.2.2. Thermo Fisher Scientific NGS Platforms/Instruments 7.2.3. Pacific Biosciences NGS Platforms/Instruments 7.2.4. Oxford Nanopore NGS Platforms/Instruments 7.2.5. Others 7.3. Software 7.4. Services 8. Latin America Next Generation Sequencing Market, By Sequencing Type Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Whole Genome Sequencing 8.2. Whole Exome Sequencing 8.3. Targeted Sequencing 8.4. Others 9. Latin America Next Generation Sequencing Market, By Technology Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Sequencing by Synthesis 9.2. Ion Semiconductor Sequencing 9.3. Sequencing by Ligation 9.4. Single-Molecule Real-Time Sequencing 9.5. Nanopore Sequencing 9.6. Others 10. Latin America Next Generation Sequencing Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Clinical Application 10.1.1. Oncology 10.1.2. Reproductive Health Diagnostics 10.1.2.1. Non-Invasive Pre-natal Testing 10.1.2.2. Carrier Screening 10.1.2.3. In-Vitro fertilization 10.1.2.4. Newborn Screening 10.1.3. Cardiovascular 10.1.4. Others 10.2. Research Application 10.2.1. Drug Discovery 10.2.2. Agriculture & Animal Research 10.2.3. Others 11. Latin America Next Generation Sequencing Market, By End user Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Clinical Diagnostic Laboratories 11.2. Pharmaceutical & Biotechnology Companies 11.3. Academic & Research Institutes 11.4. Others 12. Latin America Next Generation Sequencing Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028 13. Market Share Analysis and Competitive Landscape 13.1. Latin America Landscape - Key Players, Revenue and Presence 13.2. Latin America Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 13.3. Latin America Emerging Companies 13.4. Latin America - Market Share Analysis and Key Regional Players 13.5. Latin America Key Player - Growth Matrix 14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 14.1. Illumina, Inc. 14.1.1. Company Overview 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2. Thermo Fisher Scientific Inc. 14.2.1. Company Overview 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3. Pacific Biosciences of California, Inc. 14.3.1. Company Overview 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4. Qiagen N.V. 14.4.1. Company Overview 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5. Oxford Nanopore Technologies Ltd 14.5.1. Company Overview 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 14.6. Bio-Rad Laboratories, Inc. 14.6.1. Company Overview 14.6.2. Product Portfolio 14.6.3. SWOT Analysis 14.6.4. Financial Overview 14.6.5. Strategic Overview 14.7. Beckman Coulter, Inc. 14.7.1. Company Overview 14.7.2. Product Portfolio 14.7.3. SWOT Analysis 14.7.4. Financial Overview 14.7.5. Strategic Overview 14.8. PerkinElmer, Inc. 14.8.1. Company Overview 14.8.2. Product Portfolio 14.8.3. SWOT Analysis 14.8.4. Financial Overview 14.8.5. Strategic Overview 14.9. F. Hoffmann-La Roche AG 14.9.1. Company Overview 14.9.2. Product Portfolio 14.9.3. SWOT Analysis 14.9.4. Financial Overview 14.9.5. Strategic Overview 14.10.10x Genomics, Inc. . 14.10.1. Company Overview 14.10.2. Product Portfolio 14.10.3. SWOT Analysis 14.10.4. Financial Overview 14.10.5. Strategic Overview 14.11.Macrogen Inc. 14.11.1. Company Overview 14.11.2. Product Portfolio 14.11.3. SWOT Analysis 14.11.4. Financial Overview 14.11.5. Strategic Overview 14.12.Partek Inc. 14.12.1. Company Overview 14.12.2. Product Portfolio 14.12.3. SWOT Analysis 14.12.4. Financial Overview 14.12.5. Strategic Overview 14.13.Agilent Technologies Inc. 14.13.1. Company Overview 14.13.2. Product Portfolio 14.13.3. SWOT Analysis 14.13.4. Financial Overview 14.13.5. Strategic Overview 14.14.Genomatix Software GmbH 14.14.1. Company Overview 14.14.2. Product Portfolio 14.14.3. SWOT Analysis 14.14.4. Financial Overview 14.14.5. Strategic Overview 14.15 GATC Biotech Ag 14.15.1. Company Overview 14.15.2. Product Portfolio 14.15.3. SWOT Analysis 14.15.4. Financial Overview 14.15.5. Strategic Overview 15. Pre and Post COVID-19 Impact 15.1. Positive influence on the healthcare industry 15.2. The financial disruption of the manufacturing sector 15.3. Impact of COVID-19 on emerging companies 15.4. Significant mandates in the healthcare regulations initiated by administrations 15.5. The overall economic slowdown of the developing and developed nations 16. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders
2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study
3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights
4. Global Latin America Next Generation Sequencing Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Latin America Next Generation Sequencing Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Latin America Next Generation Sequencing Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Latin America Next Generation Sequencing Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Consumables 7.1.1. Sample Preparation Consumables 7.1.1.1. DNA Fragmentation & Amplification 7.1.1.2. Library Preparation & Target Enrichment 7.1.1.3. Quality Control 7.1.2. Other Consumables 7.2. NGS Platforms/Instruments 7.2.1. Illumina NGS Platforms/Instruments 7.2.2. Thermo Fisher Scientific NGS Platforms/Instruments 7.2.3. Pacific Biosciences NGS Platforms/Instruments 7.2.4. Oxford Nanopore NGS Platforms/Instruments 7.2.5. Others 7.3. Software 7.4. Services
8. Latin America Next Generation Sequencing Market, By Sequencing Type Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Whole Genome Sequencing 8.2. Whole Exome Sequencing 8.3. Targeted Sequencing 8.4. Others
9. Latin America Next Generation Sequencing Market, By Technology Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Sequencing by Synthesis 9.2. Ion Semiconductor Sequencing 9.3. Sequencing by Ligation 9.4. Single-Molecule Real-Time Sequencing 9.5. Nanopore Sequencing 9.6. Others
10. Latin America Next Generation Sequencing Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Clinical Application 10.1.1. Oncology 10.1.2. Reproductive Health Diagnostics 10.1.2.1. Non-Invasive Pre-natal Testing 10.1.2.2. Carrier Screening 10.1.2.3. In-Vitro fertilization 10.1.2.4. Newborn Screening 10.1.3. Cardiovascular 10.1.4. Others 10.2. Research Application 10.2.1. Drug Discovery 10.2.2. Agriculture & Animal Research 10.2.3. Others
11. Latin America Next Generation Sequencing Market, By End user Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Clinical Diagnostic Laboratories 11.2. Pharmaceutical & Biotechnology Companies 11.3. Academic & Research Institutes 11.4. Others
12. Latin America Next Generation Sequencing Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028
13. Market Share Analysis and Competitive Landscape 13.1. Latin America Landscape - Key Players, Revenue and Presence 13.2. Latin America Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 13.3. Latin America Emerging Companies 13.4. Latin America - Market Share Analysis and Key Regional Players 13.5. Latin America Key Player - Growth Matrix
14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 14.1. Illumina, Inc. 14.1.1. Company Overview 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2. Thermo Fisher Scientific Inc. 14.2.1. Company Overview 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3. Pacific Biosciences of California, Inc. 14.3.1. Company Overview 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4. Qiagen N.V. 14.4.1. Company Overview 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5. Oxford Nanopore Technologies Ltd 14.5.1. Company Overview 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 14.6. Bio-Rad Laboratories, Inc. 14.6.1. Company Overview 14.6.2. Product Portfolio 14.6.3. SWOT Analysis 14.6.4. Financial Overview 14.6.5. Strategic Overview 14.7. Beckman Coulter, Inc. 14.7.1. Company Overview 14.7.2. Product Portfolio 14.7.3. SWOT Analysis 14.7.4. Financial Overview 14.7.5. Strategic Overview 14.8. PerkinElmer, Inc. 14.8.1. Company Overview 14.8.2. Product Portfolio 14.8.3. SWOT Analysis 14.8.4. Financial Overview 14.8.5. Strategic Overview 14.9. F. Hoffmann-La Roche AG 14.9.1. Company Overview 14.9.2. Product Portfolio 14.9.3. SWOT Analysis 14.9.4. Financial Overview 14.9.5. Strategic Overview 14.10.10x Genomics, Inc. . 14.10.1. Company Overview 14.10.2. Product Portfolio 14.10.3. SWOT Analysis 14.10.4. Financial Overview 14.10.5. Strategic Overview 14.11.Macrogen Inc. 14.11.1. Company Overview 14.11.2. Product Portfolio 14.11.3. SWOT Analysis 14.11.4. Financial Overview 14.11.5. Strategic Overview 14.12.Partek Inc. 14.12.1. Company Overview 14.12.2. Product Portfolio 14.12.3. SWOT Analysis 14.12.4. Financial Overview 14.12.5. Strategic Overview 14.13.Agilent Technologies Inc. 14.13.1. Company Overview 14.13.2. Product Portfolio 14.13.3. SWOT Analysis 14.13.4. Financial Overview 14.13.5. Strategic Overview 14.14.Genomatix Software GmbH 14.14.1. Company Overview 14.14.2. Product Portfolio 14.14.3. SWOT Analysis 14.14.4. Financial Overview 14.14.5. Strategic Overview 14.15 GATC Biotech Ag 14.15.1. Company Overview 14.15.2. Product Portfolio 14.15.3. SWOT Analysis 14.15.4. Financial Overview 14.15.5. Strategic Overview
15. Pre and Post COVID-19 Impact 15.1. Positive influence on the healthcare industry 15.2. The financial disruption of the manufacturing sector 15.3. Impact of COVID-19 on emerging companies 15.4. Significant mandates in the healthcare regulations initiated by administrations 15.5. The overall economic slowdown of the developing and developed nations
16. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics